From candidate to default: the company has just been placed inside buyers' own purchasing systems
The model's full reasoning — Q1 2017 call → NO我们根据提供的电话会议记录,判断管理层是否描述了公司最近从“需要说服买家考虑的候选者”转变为“买家自身采购、报销、配方、规格、采购、网络、目录或计划系统中的已批准、指定、列出、合格、注册、报销或预授权选择”,并且这种准入状态是新的,大部分量尚未反映在报告结果中。 在记录中,管理层提到了几个方面: - 在MST(湿鼻烟)方面,他们正在“追求在连锁店领域的进一步分销”,并提到“在接下来的几个季度中,我们希望能有一些好消息”。这暗示分销扩展正在进行中,但尚未完全实现。 - 在Wind River收购的五个区域性无烟烟草品牌方面,他们“按计划将在今年晚些时候扩大零售分销”,并称这是一个“Plug-n-Play机会”,可以利用现有SG&A基础设施。这听起来像是将品牌引入新市场,但尚未完成。 - 在VaporBeast方面,他们提到“VaporBeast给了我们进入非传统零售渠道的现成途径”,并正在“制定市场推广计划,将TPV产品通过VaporBeast分销平台推向非传统零售”。但这是关于分销渠道,而非被列入买家系统。 - 关于VaporShark的合作伙伴关系,他们表示“这种关系还处于初期阶段,我们正在合作确定未来最佳的工作关系”,并预计下个季度提供初步想法。这也不是已完成的准入。 没有明确提到公司已被列入任何批准供应商名单、采购计划、报销目录等。管理层谈论的是分销扩展、销售队伍扩张、收购整合,但未描述公司已进入一个“默认”系统,使得未来业务无需逐个销售即可自动流入。他们提到“我们正在追求在连锁店领域的进一步分销”,但这是未来计划,而非已实现的状态。 因此,答案应为NO。
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| WRBY | Warby Parker Inc. | Q1 2024 | 2024-05-09 | A |
| AZEK | The AZEK Company Inc. | Q2 2024 | 2024-05-08 | B+ |
| DXCM | DexCom, Inc. | Q4 2023 | 2024-02-08 | B+ |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| INGN | Inogen, Inc. | Q1 2023 | 2023-05-05 | F |
| HBB | Hamilton Beach Brands Holding Company | Q3 2022 | 2022-11-05 | C |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| MGNI | Magnite, Inc. | Q1 2022 | 2022-05-04 | D |
| AGIO | Agios Pharmaceuticals, Inc. | Q3 2018 | 2018-11-01 | C |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
PRIM · Q2 2018 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, qua...YES The transcript shows management describing exactly this shift for the newly acquired T&D segment: after the Willbros acquisition (closed June 1, 2018), the T&D Group gained access to major utilities that had been hesitant due to prior financial concerns. With Primoris as parent, they signed new awards from the 3 largest electrical utilities (one announced MSA, two not yet announced), allowing work to flow under existing relationships without repeated persuasion. Management explicitly ties this to the recent acquisition and notes the MSA backlog now at $1.1 billion (first time exceeding $1 billion), with one-year estimated MSA revenue at $1.1 billion and continued growth expected.
AGIO · Q3 2018 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, qua...YES The transcript shows management describing exactly this transition for TIBSOVO. Steve Hoerter states that the company launched in July 2018 and is now receiving reimbursement with “no payer-related coverage issues,” with the payer mix (60% Medicare, 35% commercial) reflecting routine placement in those systems. He further notes that initial prescriptions are being written by over 100 unique prescribers and that awareness is already above 90%, confirming the product has moved from candidate status into the reimbursement and purchasing pathways. Because the launch is only a few months old at the time of the call, the $4.
AZEK · Q2 2024 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, etc...YES The transcript shows management describing recent and incremental shelf-space gains in both pro and retail channels as a new development that will support growth in 2025, with investments planned for Q4 to enable these gains. This is framed as moving beyond prior years' steady execution into fresh wins that create a tailwind for future 2025 volume, where the company is now positioned to benefit from expanded availability in buyer systems (catalogs, dealer networks, and retail displays) without needing to re-persuade for each order.